Pre-existing immunity to endemic human coronaviruses does not affect the immune response to SARS-CoV-2 spike in a murine vaccination model

Cited 1 time in scopus
Metadata Downloads

Full metadata record

DC FieldValueLanguage
dc.contributor.authorAhn Young Jeong-
dc.contributor.authorPureum Lee-
dc.contributor.authorMoo-Seung Lee-
dc.contributor.authorDoo-Jin Kim-
dc.date.accessioned2023-05-15T16:33:11Z-
dc.date.available2023-05-15T16:33:11Z-
dc.date.issued2023-
dc.identifier.issn1598-2629-
dc.identifier.urihttps://oak.kribb.re.kr/handle/201005/31731-
dc.description.abstractEndemic human coronaviruses (HCoVs) have been evidenced to be cross-reactive to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Although a correlation exists between the immunological memory to HCoVs and coronavirus disease 2019 (COVID-19) severity, there is little experimental evidence for the effects of HCoV memory on the efficacy of COVID-19 vaccines. Here, we investigated the Ag-specific immune response to COVID-19 vaccines in the presence or absence of immunological memory against HCoV spike Ags in a mouse model. Pre-existing immunity against HCoV did not affect the COVID-19 vaccine-mediated humoral response with regard to Ag-specific total IgG and neutralizing Ab levels. The specific T cell response to the COVID-19 vaccine Ag was also unaltered, regardless of pre-exposure to HCoV spike Ags. Taken together, our data suggest that COVID-19 vaccines elicit comparable immunity regardless of immunological memory to spike of endemic HCoVs in a mouse model.-
dc.publisherKorea Soc-Assoc-Inst-
dc.titlePre-existing immunity to endemic human coronaviruses does not affect the immune response to SARS-CoV-2 spike in a murine vaccination model-
dc.title.alternativePre-existing immunity to endemic human coronaviruses does not affect the immune response to SARS-CoV-2 spike in a murine vaccination model-
dc.typeArticle-
dc.citation.titleImmune Network-
dc.citation.number2-
dc.citation.endPagee19-
dc.citation.startPagee19-
dc.citation.volume23-
dc.contributor.affiliatedAuthorAhn Young Jeong-
dc.contributor.affiliatedAuthorPureum Lee-
dc.contributor.affiliatedAuthorMoo-Seung Lee-
dc.contributor.affiliatedAuthorDoo-Jin Kim-
dc.contributor.alternativeName정안영-
dc.contributor.alternativeName이푸름-
dc.contributor.alternativeName이무승-
dc.contributor.alternativeName김두진-
dc.identifier.bibliographicCitationImmune Network, vol. 23, no. 2, pp. e19-e19-
dc.identifier.doi10.4110/in.2023.23.e19-
dc.subject.keywordHuman coronavirus (HCoV)-
dc.subject.keywordPre-existing immunity-
dc.subject.keywordSARS-CoV-2-
dc.subject.keywordCOVID-19 vaccine-
dc.subject.keywordCross-reactivity-
dc.subject.localSARS-CoV-2-
dc.subject.localSARS-Cov-2-
dc.subject.localCOVID-19 vaccine-
dc.subject.localCovid19 vaccine-
dc.subject.localCross-reactivity-
dc.description.journalClassY-
Appears in Collections:
Division of Research on National Challenges > Environmental diseases research center > 1. Journal Articles
Division of Research on National Challenges > Infectious Disease Research Center > 1. Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.